BEAR III Clinical Study
The BEAR Implant is the first medical advancement to enable your body to heal its own torn anterior cruciate ligament (ACL). That’s a big deal, because until now your ACL would have been replaced with either another tendon from your body or a tendon from a deceased donor. The BEAR Implant is different because it works with your own blood to heal the torn ends of your ACL back together.
The BEAR Implant was approved by the U.S. Food and Drug Administration in 2020, and Miach continues to expand its base of evidence through post-market and label expansion studies. BEAR III is a multi-center study in which all participants received the BEAR Implant to treat their ACL tears. Enrollment completed in 2023, and patients will be followed for 10 years.